Apatinib Combined With S-1 as Maintenance Therapy for HER-2 Negatived Gastric Cancer
NCT03950141
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER_GOV
Sponsor class
Conditions
HER-2 Negatived Gastric Cancer
Interventions
DRUG:
Apatinib and S-1
Sponsor
Beijing Hospital
Collaborators
[object Object]